| Financial Year |
March 31 2023 |
| Monetary Funds |
57,307,987.95 |
| Held-for-trading Financial Assets |
12,176,686.03 |
| Notes Receivable |
4,258,767.58 |
| Accounts Receivable |
276,899,660.98 |
| Advances to Suppliers |
4,524,836.85 |
| Other Receivables |
18,141,409.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
76,784,740.48 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
177,136.97 |
| Total Current Assets |
468,617,713.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
56,745,905.17 |
| Under-construction Projects |
295,675.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
15,609,085.13 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,382,441.87 |
| Deferred Income Tax Assets |
7,893,287.21 |
| Other Non-Current Assets |
458,043.69 |
| Sub-Total of Non-Current Assets |
84,111,566.84 |
| Total Assets |
552,729,280.40 |
| Short-Term Loans |
16,022,735.04 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
78,598,792.41 |
| Accounts Received In Advance |
674,318.61 |
| Employee Compensation Payable |
5,695,866.72 |
| Taxes Payable |
5,756,582.65 |
| Interest Payable |
-- |
| Dividend Payable |
1,409,557.48 |
| Other payables |
78,257,721.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
320,012.64 |
| Other Current Liabilities |
13,176,112.66 |
| Sub-Total of Current Liabilities |
217,335,302.95 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,804,881.83 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,687,418.58 |
| Total Liabilities |
227,022,721.53 |
| Paid-In Capital(Or Share Stock) |
193,440,000.00 |
| Capital Surplus |
64,715,823.67 |
| Surplus Reserve |
17,826,685.34 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
42,373,197.80 |
| Minority Stockholder's Interest |
7,350,852.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
318,355,706.81 |
| Owner's Equity（Stockholder's Equity） |
325,706,558.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
552,729,280.40 |
